PLAYSTUDIOS Sees FY22 Revenue $275M-$285M Vs $276.39M Est.

Outlook The Company is updating its expectation for full-year 2022 revenue to be in the range of $275.0 million to $285.0 million. In addition, the full-year AEBITDA is now expected to be in the range

Outlook

The Company is updating its expectation for full-year 2022 revenue to be in the range of $275.0 million to $285.0 million. In addition, the full-year AEBITDA is now expected to be in the range of $32.0 million to $35.0 million.

We have not provided the most directly comparable GAAP measure for our AEBITDA outlook because certain items that are part of the projected non-GAAP financial measure are outside of our control or cannot be reasonably estimated without unreasonable effort.

Total
0
Shares
Related Posts
Read More

AstraZeneca Announced Ultomiris Showed Zero Relapses in Adults With Neuromyelitis Optica Spectrum Disorder With Median Treatment Duration of 73 Weeks

Results from CHAMPION-NMOSD trial demonstrated Ultomiris reduced the risk of relapse in AQP4 Ab+ NMOSD by 98.6% compared to placebo. Ultomiris also showed a lower proportion of patients experiencing clinically important worsening in Hauser Ambulatory Index score, a measure of patient mobility.

AZN